Methicillin-resistant Staphyloccus aureus (MRSA) colonisation Infections and Infestations Methicillin-resistant Staphyloccus aureus
Conditions
Interventions
Nasal and skin swab and urinary catheter sample where appropriate from residents in both phases 1 and 2. In phase 2, homes assigned to the intervention group will receive an audit of current infection
Sponsors
Queens University Belfast (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Phase 1: all nursing homes in the Northern Board will be asked to participate. Within these homes, all residents and staff will be invited to participate. Phase 2: For a nursing home to be considered in this phase, it must have at least 20 consenting adults.
Exclusion criteria
Exclusion criteria: Nursing home residents who are terminally ill, in a coma or not deemed fit to personally give consent and have no next-of-kin available to give consent, will be excluded from both phases of the trial. For staff, there are no specific exclusion criteria, other than failure to provide written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In phase 1, determination of MRSA prevalence in nursing homes in Northern Health and Social Services (NHSSB). In phase 2, the prevalence of MRSA in intervention homes compared to control homes following infection control intervention, audit and feedback. | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed